High-sensitivity C-reactive protein and mobility disability in older adults

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Objective: to determine the association of high sensitivity C-reactive protein (HsCRP) levels with a risk of mobility disability and decline in older adults with and without vascular disease. Design: prospective cohort. Setting: community-residing population.Subjects: six hundred and twenty-four adults age 70 and older (62% women) with gait and HsCRP assessments. Main outcome measures: incident mobility disability (velocity <70 cm/s) and annual rates of decline on gait velocity. Results: elevated HsCRP levels (≥3 mg/l) at baseline present in 224 of the 624 eligible subjects was associated with a faster annual decline in gait velocity of 0.91 cm/s (P = 0.02). Subjects with elevated HsCRP levels had increased risk of mobility disability (hazard ratio: 1.85, 95% CI: 1.09-3.14). Each one-unit increase in log HsCRP levels in the 406 subjects without prevalent mobility disability was associated with increased risk of mobility disability (hazard ratio: 1.33, 95% CI: 1.05-1.68). The association of baseline HsCRP levels with mobility disability and decline was stronger in the 224 individuals without vascular disease. The associations were not significant in the 400 subjects with vascular disease. Conclusions: HsCRP levels predict mobility disability and accelerated decline in walking speed in older adults. These associations were stronger in those without vascular disease.

Original languageEnglish (US)
Article numberafs038
Pages (from-to)541-545
Number of pages5
JournalAge and Ageing
Volume41
Issue number4
DOIs
StatePublished - Jul 2012

Fingerprint

C-Reactive Protein
Vascular Diseases
Gait
Outcome Assessment (Health Care)
Population

Keywords

  • Cohort study
  • Epidemiology
  • Gait
  • Inflammation elderly

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Cite this

High-sensitivity C-reactive protein and mobility disability in older adults. / Verghese, Joe; Holtzer, Roee; Lipton, Richard B.; Wang, Cuiling.

In: Age and Ageing, Vol. 41, No. 4, afs038, 07.2012, p. 541-545.

Research output: Contribution to journalArticle

@article{e441a4d4729346b1b8de8d99f4bdf883,
title = "High-sensitivity C-reactive protein and mobility disability in older adults",
abstract = "Objective: to determine the association of high sensitivity C-reactive protein (HsCRP) levels with a risk of mobility disability and decline in older adults with and without vascular disease. Design: prospective cohort. Setting: community-residing population.Subjects: six hundred and twenty-four adults age 70 and older (62{\%} women) with gait and HsCRP assessments. Main outcome measures: incident mobility disability (velocity <70 cm/s) and annual rates of decline on gait velocity. Results: elevated HsCRP levels (≥3 mg/l) at baseline present in 224 of the 624 eligible subjects was associated with a faster annual decline in gait velocity of 0.91 cm/s (P = 0.02). Subjects with elevated HsCRP levels had increased risk of mobility disability (hazard ratio: 1.85, 95{\%} CI: 1.09-3.14). Each one-unit increase in log HsCRP levels in the 406 subjects without prevalent mobility disability was associated with increased risk of mobility disability (hazard ratio: 1.33, 95{\%} CI: 1.05-1.68). The association of baseline HsCRP levels with mobility disability and decline was stronger in the 224 individuals without vascular disease. The associations were not significant in the 400 subjects with vascular disease. Conclusions: HsCRP levels predict mobility disability and accelerated decline in walking speed in older adults. These associations were stronger in those without vascular disease.",
keywords = "Cohort study, Epidemiology, Gait, Inflammation elderly",
author = "Joe Verghese and Roee Holtzer and Lipton, {Richard B.} and Cuiling Wang",
year = "2012",
month = "7",
doi = "10.1093/ageing/afs038",
language = "English (US)",
volume = "41",
pages = "541--545",
journal = "Age and Ageing",
issn = "0002-0729",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - High-sensitivity C-reactive protein and mobility disability in older adults

AU - Verghese, Joe

AU - Holtzer, Roee

AU - Lipton, Richard B.

AU - Wang, Cuiling

PY - 2012/7

Y1 - 2012/7

N2 - Objective: to determine the association of high sensitivity C-reactive protein (HsCRP) levels with a risk of mobility disability and decline in older adults with and without vascular disease. Design: prospective cohort. Setting: community-residing population.Subjects: six hundred and twenty-four adults age 70 and older (62% women) with gait and HsCRP assessments. Main outcome measures: incident mobility disability (velocity <70 cm/s) and annual rates of decline on gait velocity. Results: elevated HsCRP levels (≥3 mg/l) at baseline present in 224 of the 624 eligible subjects was associated with a faster annual decline in gait velocity of 0.91 cm/s (P = 0.02). Subjects with elevated HsCRP levels had increased risk of mobility disability (hazard ratio: 1.85, 95% CI: 1.09-3.14). Each one-unit increase in log HsCRP levels in the 406 subjects without prevalent mobility disability was associated with increased risk of mobility disability (hazard ratio: 1.33, 95% CI: 1.05-1.68). The association of baseline HsCRP levels with mobility disability and decline was stronger in the 224 individuals without vascular disease. The associations were not significant in the 400 subjects with vascular disease. Conclusions: HsCRP levels predict mobility disability and accelerated decline in walking speed in older adults. These associations were stronger in those without vascular disease.

AB - Objective: to determine the association of high sensitivity C-reactive protein (HsCRP) levels with a risk of mobility disability and decline in older adults with and without vascular disease. Design: prospective cohort. Setting: community-residing population.Subjects: six hundred and twenty-four adults age 70 and older (62% women) with gait and HsCRP assessments. Main outcome measures: incident mobility disability (velocity <70 cm/s) and annual rates of decline on gait velocity. Results: elevated HsCRP levels (≥3 mg/l) at baseline present in 224 of the 624 eligible subjects was associated with a faster annual decline in gait velocity of 0.91 cm/s (P = 0.02). Subjects with elevated HsCRP levels had increased risk of mobility disability (hazard ratio: 1.85, 95% CI: 1.09-3.14). Each one-unit increase in log HsCRP levels in the 406 subjects without prevalent mobility disability was associated with increased risk of mobility disability (hazard ratio: 1.33, 95% CI: 1.05-1.68). The association of baseline HsCRP levels with mobility disability and decline was stronger in the 224 individuals without vascular disease. The associations were not significant in the 400 subjects with vascular disease. Conclusions: HsCRP levels predict mobility disability and accelerated decline in walking speed in older adults. These associations were stronger in those without vascular disease.

KW - Cohort study

KW - Epidemiology

KW - Gait

KW - Inflammation elderly

UR - http://www.scopus.com/inward/record.url?scp=84864026024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864026024&partnerID=8YFLogxK

U2 - 10.1093/ageing/afs038

DO - 10.1093/ageing/afs038

M3 - Article

VL - 41

SP - 541

EP - 545

JO - Age and Ageing

JF - Age and Ageing

SN - 0002-0729

IS - 4

M1 - afs038

ER -